...
首页> 外文期刊>European review for medical and pharmacological sciences. >An investigation of the concomitant use of angiotensin-converting enzyme inhibitors, non-steroidal anti-inflammatory drugs and diuretics
【24h】

An investigation of the concomitant use of angiotensin-converting enzyme inhibitors, non-steroidal anti-inflammatory drugs and diuretics

机译:血管紧张素转换酶抑制剂,非甾体类抗炎药和利尿剂同时使用的研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: To determine in retrospective data the prevalence at hospital discharge of co-prescribing angiotensin-converting enzyme inhibitors (ACE-I) and non-steroidal anti-inflammatory drugs (NSAIDs) and ACE-I/NSAIDs and diuretics and to identify factors associated with the co-prescription. Secondary, we evaluated the extent of serum creatinine and potassium monitoring in patients treated with ACE-I and these associations and determined the prevalence of values above the upper normal limit (UNL) in monitored patients.
机译:目的:在回顾性数据中确定共同处方血管紧张素转换酶抑制剂(ACE-I)和非甾体抗炎药(NSAIDs)和ACE-I / NSAIDs和利尿剂的出院率,并确定相关因素与共同处方。其次,我们评估了接受ACE-1治疗的患者的血清肌酐和钾监测程度以及这些关联,并确定了受监测患者中高于正常上限(UNL)的患病率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号